Editorial
Antiviral prophylaxis of cytomegalovirus reactivation in immune competent patients—the jury remains out
Abstract
Cytomegalovirus (CMV) has been recognized as a pathogen in immunosuppressed patients for many years, with viral reactivation after transplantation continuing to plague many patients.
